Ellen L Wolfe1, Thomas Davis, Joseph Guydish, Kevin L Delucchi. 1. Family Health Care Nursing (E.L.W.), University of California, San Francisco, San Francisco General Hospital, San Francisco, CA 94110, USA. ewolfe@sfghpeds.ucsf.edu
Abstract
OBJECTIVE: To analyze the relationship between perinatal drug/alcohol use and maternal, fetal, neonatal, and postneonatal mortality. STUDY DESIGN: Linked California discharge, birth and death certificate data from 1991-1998 were used to identify drug/alcohol-diagnosed births. Mortality relative risk (RR) ratios were calculated and logistic models were generated for mortality outcomes. RESULTS: Among 4,536,701 birth records, 1.20% contained drug/alcohol discharge diagnostic codes (n=54,290). The unadjusted RRs for maternal (RR=2.7), fetal (RR=1.3), neonatal (RR=2.4), and postneonatal (RR=4.3) mortality were increased for drug/alcohol-diagnosed births. After controlling for potential confounding, the odds of maternal death for cocaine use (OR=2.15) remained significant as did amphetamine (OR=1.77), cocaine (OR=1.43), polydrug (OR=2.01) and other drug/alcohol use (OR=1.79) for postneonatal mortality. CONCLUSIONS: The association of cocaine use with maternal mortality and any drug/alcohol use with postneonatal mortality supports screening and identifying women using illicit drugs and alcohol during pregnancy. Increased collaboration with drug treatment programs and closer follow-up for drug-using women and their children may improve mortality outcomes.
OBJECTIVE: To analyze the relationship between perinatal drug/alcohol use and maternal, fetal, neonatal, and postneonatal mortality. STUDY DESIGN: Linked California discharge, birth and death certificate data from 1991-1998 were used to identify drug/alcohol-diagnosed births. Mortality relative risk (RR) ratios were calculated and logistic models were generated for mortality outcomes. RESULTS: Among 4,536,701 birth records, 1.20% contained drug/alcohol discharge diagnostic codes (n=54,290). The unadjusted RRs for maternal (RR=2.7), fetal (RR=1.3), neonatal (RR=2.4), and postneonatal (RR=4.3) mortality were increased for drug/alcohol-diagnosed births. After controlling for potential confounding, the odds of maternal death for cocaine use (OR=2.15) remained significant as did amphetamine (OR=1.77), cocaine (OR=1.43), polydrug (OR=2.01) and other drug/alcohol use (OR=1.79) for postneonatal mortality. CONCLUSIONS: The association of cocaine use with maternal mortality and any drug/alcohol use with postneonatal mortality supports screening and identifying women using illicit drugs and alcohol during pregnancy. Increased collaboration with drug treatment programs and closer follow-up for drug-using women and their children may improve mortality outcomes.
Authors: Rosemary H Kelly; Joan Russo; Victoria L Holt; Beate H Danielsen; Douglas F Zatzick; Edward Walker; Wayne Katon Journal: Obstet Gynecol Date: 2002-08 Impact factor: 7.661
Authors: Jerrie S Refuerzo; Robert J Sokol; Sean C Blackwell; Stanley M Berry; James J Janisse; Yoram Sorokin Journal: Am J Obstet Gynecol Date: 2002-06 Impact factor: 8.661
Authors: Marian Jarlenski; Elizabeth E Krans; Qingwen Chen; Scott D Rothenberger; Abigail Cartus; Kara Zivin; Lisa M Bodnar Journal: Drug Alcohol Depend Date: 2020-08-20 Impact factor: 4.492
Authors: Putu Duff; Jean Shoveller; Ruth Zhang; Debbie Alexson; Julio S G Montaner; Kate Shannon Journal: BMC Pregnancy Childbirth Date: 2011-08-18 Impact factor: 3.007
Authors: Natasia S Courchesne; Laramie R Smith; María Luisa Zúñiga; Christina D Chambers; Mark B Reed; Jerasimos Ballas; Carla B Marienfeld Journal: Alcohol Clin Exp Res Date: 2021-09-19 Impact factor: 3.455